Skip to main content

Advertisement

Log in

Alternatively activated macrophages promote airway inflammation through JAK3–STAT5–Fra2 in asthma

  • Original Research Article
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Background

Fos-related antigen-2 (Fra-2) is a transcription factor belonging to the activator protein 1 (AP-1) family, which is associated with many chronic airway diseases such as asthma. Alternatively activated (M2) macrophages are associated with Fra2 in airway diseases such as pulmonary fibrosis. However, there is no specific study that explores the relationship between M2 macrophages and Fra2 in asthma.

Objective

We hypothesized that a potential mechanism of allergic asthma could be that Fra2 is highly expressed in M2 macrophages through JAK3–STAT5 and facilitates the production of downstream T-helper 2 (Th2) cytokines, thus promoting the pathogenesis of asthma.

Methods

Peripheral venous blood and airway tissue samples of patients with asthma and controls were obtained. Moreover, a C57BL/6 mouse model of asthma was established. Fra2 expression was detected using immunohistochemistry and immunofluorescence. Macrophages were obtained by flow sorting, and expression of the JAK3–STAT5–Fra2 signaling pathway was determined using PCR and western blotting. Enzyme-linked immunosorbent assay was used to determine M2 macrophage-associated Th2-type cytokine levels.

Results

Fra2 was highly expressed in patients with asthma and asthmatic mice. The JAK3–STAT5 was a signal pathway related to the high expression of Fra2 in M2 macrophages. Moreover, we found that Fra2 could affect the production of Th2 cytokines downstream of M2 macrophages, including interleukin 4 (IL-4) and IL-13.

Conclusion

M2 macrophages could promote airway inflammation through JAK3–STAT5–Fra2 to induce allergic asthma. Our study offers a new insight to further understand the pathogenesis of asthma and also provides a new direction for targeted treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Availability of data and materials

Experimental data related to this study can be obtained from the corresponding author upon reasonable request.

References

  1. Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391(10122):783–800.

    Article  Google Scholar 

  2. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2021. Available from: www.ginasthma.org

  3. Schatz M, Rosenwasser L. The allergic asthma phenotype. J Allergy Clin Immunol Pract. 2014;2(6):645–9.

    Article  Google Scholar 

  4. Romanet-Manent S, Charpin D, Magnan A, Lanteaume A, Vervloet D, EGEA Cooperative Group. Allergic vs nonallergic asthma: what makes the difference? Allergy. 2002;57(7):607–13.

    Article  Google Scholar 

  5. Kanani AS, Broder I, Greene JM, Tarlo SM. Correlation between nasal symptoms and asthma severity in patients with atopic and nonatopic asthma. Ann Allergy Asthma Immunol. 2005;94(3):341–7.

    Article  Google Scholar 

  6. Novak N, Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol. 2003;112(2):252–62.

    Article  Google Scholar 

  7. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006;368(9537):804–13.

    Article  CAS  Google Scholar 

  8. Finotto S. Resolution of allergic asthma. Semin Immunopathol. 2019;41(6):665–74.

    Article  Google Scholar 

  9. Tumes DJ, Papadopoulos M, Endo Y, Onodera A, Hirahara K, Nakayama T. Epigenetic regulation of T-helper cell differentiation, memory, and plasticity in allergic asthma. Immunol Rev. 2017;278(1):8–19.

    Article  CAS  Google Scholar 

  10. Kim CK, Kim SW, Park CS, Kim BI, Kang H, Koh YY. Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. J Allergy Clin Immunol. 2003;112(1):64–71.

    Article  CAS  Google Scholar 

  11. Abdelaziz MH, Abdelwahab SF, Wan J, et al. Alternatively activated macrophages; a double-edged sword in allergic asthma. J Transl Med. 2020;18(1):58.

    Article  CAS  Google Scholar 

  12. Cai Y, Sugimoto C, Arainga M, Alvarez X, Didier ES, Kuroda MJ. In vivo characterization of alveolar and interstitial lung macrophages in rhesus macaques: implications for understanding lung disease in humans. J Immunol. 2014;192(6):2821–9.

    Article  CAS  Google Scholar 

  13. Yang M, Kumar RK, Hansbro PM, Foster PS. Emerging roles of pulmonary macrophages in driving the development of severe asthma. J Leukoc Biol. 2012;91(4):557–69.

    Article  CAS  Google Scholar 

  14. Peters-Golden M. The alveolar macrophage: the forgotten cell in asthma. Am J Respir Cell Mol Biol. 2004;31(1):3–7.

    Article  CAS  Google Scholar 

  15. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009;27:451–83.

    Article  CAS  Google Scholar 

  16. Nieuwenhuizen NE, Kirstein F, Jayakumar J, et al. Allergic airway disease is unaffected by the absence of IL-4Rα-dependent alternatively activated macrophages. J Allergy Clin Immunol. 2012;130(3):743-750.e8.

    Article  CAS  Google Scholar 

  17. Moreira AP, Cavassani KA, Hullinger R, et al. Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease. J Allergy Clin Immunol. 2010;126(4):712-721.e7.

    Article  CAS  Google Scholar 

  18. Ford AQ, Dasgupta P, Mikhailenko I, Smith EM, Noben-Trauth N, Keegan AD. Adoptive transfer of IL-4Rα+ macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation. BMC Immunol. 2012;13:6.

    Article  CAS  Google Scholar 

  19. Girodet PO, Nguyen D, Mancini JD, et al. Alternative macrophage activation is increased in asthma. Am J Respir Cell Mol Biol. 2016;55(4):467–75.

    Article  CAS  Google Scholar 

  20. Langer S, Singer CF, Hudelist G, et al. Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters. Eur J Gynaecol Oncol. 2006;27(4):345–52.

    CAS  PubMed  Google Scholar 

  21. Wang ZQ, Ovitt C, Grigoriadis AE, Möhle-Steinlein U, Rüther U, Wagner EF. Bone and haematopoietic defects in mice lacking c-fos. Nature. 1992;360(6406):741–5.

    Article  CAS  Google Scholar 

  22. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene. 2001;20(19):2390–400.

    Article  CAS  Google Scholar 

  23. Eferl R, Zenz R, Theussl HC, Wagner EF. Simultaneous generation of fra-2 conditional and fra-2 knock-out mice. Genesis. 2007;45(7):447–51.

    Article  CAS  Google Scholar 

  24. Eferl R, Hasselblatt P, Rath M, et al. Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Proc Natl Acad Sci U S A. 2008;105(30):10525–30.

    Article  CAS  Google Scholar 

  25. Reich N, Maurer B, Akhmetshina A, et al. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis. Arthritis Rheum. 2010;62(1):280–90.

    Article  CAS  Google Scholar 

  26. Birnhuber A, Crnkovic S, Biasin V, et al. IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis. Eur Respir J. 2019;54(3):1900154.

    Article  CAS  Google Scholar 

  27. Biasin V, Marsh LM, Egemnazarov B, et al. Meprin β, a novel mediator of vascular remodelling underlying pulmonary hypertension. J Pathol. 2014;233(1):7–17.

    Article  CAS  Google Scholar 

  28. Gungl A, Biasin V, Wilhelm J, Olschewski A, Kwapiszewska G, Marsh LM. Fra2 overexpression in mice leads to non-allergic asthma development in an IL-13 dependent Manner. Front Immunol. 2018;9:2018.

    Article  Google Scholar 

  29. Ucero AC, Bakiri L, Roediger B, et al. Fra-2-expressing macrophages promote lung fibrosis in mice. J Clin Invest. 2019;129(8):3293–309.

    Article  Google Scholar 

  30. Saradna A, Do DC, Kumar S, Fu QL, Gao P. Macrophage polarization and allergic asthma. Transl Res. 2018;191:1–14.

    Article  CAS  Google Scholar 

  31. Padem N, Saltoun C. Classification of asthma. Allergy Asthma Proc. 2019;40(6):385–8.

    Article  CAS  Google Scholar 

  32. Akar-Ghibril N, Casale T, Custovic A, Phipatanakul W. Allergic endotypes and phenotypes of asthma. J Allergy Clin Immunol Pract. 2020;8(2):429–40.

    Article  Google Scholar 

  33. Holtzman MJ. Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J Clin Invest. 2012;122(8):2741–8.

    Article  CAS  Google Scholar 

  34. Castro M, Corren J, Pavord ID, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486–96.

    Article  CAS  Google Scholar 

  35. Ortega HG, Liu MC, Pavord ID, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014;371(13):1198–207.

    Article  Google Scholar 

  36. Maurer B, Busch N, Jüngel A, et al. Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation. 2009;120(23):2367–76.

    Article  CAS  Google Scholar 

  37. Higuchi T, Nakayama T, Arao T, Nishio K, Yoshie O. SOX4 is a direct target gene of FRA-2 and induces expression of HDAC8 in adult T-cell leukemia/lymphoma. Blood. 2013;121(18):3640–9.

    Article  CAS  Google Scholar 

  38. Rani A, Greenlaw R, Runglall M, Jurcevic S, John S. FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cells. PLoS ONE. 2014;9(2): e90370.

    Article  Google Scholar 

  39. Jiang Z, Zhu L. Update on the role of alternatively activated macrophages in asthma. J Asthma Allergy. 2016;9:101–7.

    Article  CAS  Google Scholar 

Download references

Funding

This work was funded by the National Natural Science Foundation of China (Grant No. 81770029).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Liang Dong.

Ethics declarations

Conflict of interest

The authors would like to declare that they have no conflict of interest.

Ethical approval

All studies involving human participants were conducted in accordance with the standards of the Ethics Committee of Shandong Provincial Qianfoshan Hospital. The Institutional Animal Care and Use Committee of Shandong University approved all animal experiments in this study.

Consent for publication

Not applicable.

Additional information

Responsible Editor: John Di Battista.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, S., Wang, J., Liu, F. et al. Alternatively activated macrophages promote airway inflammation through JAK3–STAT5–Fra2 in asthma. Inflamm. Res. 71, 873–885 (2022). https://doi.org/10.1007/s00011-022-01585-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-022-01585-z

Keywords

Navigation